Botulinum toxin (Urogen Pharma)

N/A

Report date: 2025/07/21 20:01:29

Base Information

Drug NameBotulinum toxin (Urogen Pharma)
Drug Alias Name肉毒杆菌毒素（Urogen Pharma）Botugel
ClassificationNatural product/Extract > Microbial extractBiologics
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsUrinary Bladder, OveractiveCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUrogen Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUrogen Pharma Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveCystitis, Interstitial

Other Information

ATC CodeM03AX01
Related LinksWikipediaDrugBankKEGG